ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CYT Cyteir Therapeutics Inc

3.02
0.00 (0.00%)
Pre Market
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cyteir Therapeutics Inc CYT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 3.02 10:00:00
Open Price Low Price High Price Close Price Previous Close
3.02
more quote information »

Recent News

Date Time Source Heading
08/3/202408:31EDGAR2Form 8-K - Current report
08/3/202408:30BWCyteir Announces Timeline for Voluntarily Delisting from..
06/3/202410:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202411:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202411:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
28/12/202308:00EDGAR2Form 8-K - Current report
15/12/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202308:05EDGAR2Form 8-K - Current report
06/12/202308:05EDGAR2Form 8-K - Current report
23/11/202305:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202308:01EDGAR2Form 8-K - Current report
07/11/202308:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/10/202307:14EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
12/10/202322:52EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/10/202322:51EDGAR2Form 8-K - Current report
12/10/202322:30BWOngoing Results From a Dose Expansion Cohort of CYT-0851 in..
06/10/202307:00EDGAR2Form 8-K - Current report
03/10/202307:44EDGAR2Form PREM14A - Preliminary proxy statements relating to..
08/8/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/7/202307:29EDGAR2Form 144 - Report of proposed sale of securities
01/7/202300:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/7/202300:22EDGAR2Form 8-K - Current report
30/6/202322:00BWCyteir Therapeutics Announces Discontinuation of CYT-0851..
03/6/202323:00BWPreliminary Ongoing Results with CYT-0851 in Combination..
11/5/202306:01BWCyteir Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock